Annual Working Capital
$77.67 M
-$20.56 M-20.93%
31 December 2022
Summary:
Eagle Pharmaceuticals annual working capital is currently $77.67 million, with the most recent change of -$20.56 million (-20.93%) on 31 December 2022. During the last 3 years, it has fallen by -$50.31 million (-39.31%). EGRX annual working capital is now -45.07% below its all-time high of $141.40 million, reached on 31 December 2017.EGRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$100.62 M
+$5.94 M+6.27%
30 June 2023
Summary:
Eagle Pharmaceuticals quarterly working capital is currently $100.62 million, with the most recent change of +$5.94 million (+6.27%) on 30 June 2023. EGRX quarterly working capital is now -38.03% below its all-time high of $162.36 million, reached on 30 September 2018.EGRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EGRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -39.3% | -18.4% |
| 5 y5 years | -37.5% | -26.8% |
EGRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.3% | at low | -27.4% | +59.2% |
| 5 y | 5 years | -44.8% | at low | -28.4% | +59.2% |
| alltime | all time | -45.1% | +746.3% | -38.0% | >+9999.0% |
Eagle Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $100.62 M(+6.3%) |
| Mar 2023 | - | $94.68 M(+21.9%) |
| Dec 2022 | $77.67 M(-20.9%) | $77.67 M(+22.9%) |
| Sept 2022 | - | $63.22 M(-26.1%) |
| June 2022 | - | $85.49 M(-38.3%) |
| Mar 2022 | - | $138.52 M(+41.0%) |
| Dec 2021 | $98.23 M(-23.2%) | $98.23 M(-20.3%) |
| Sept 2021 | - | $123.26 M(-5.8%) |
| June 2021 | - | $130.84 M(+7.2%) |
| Mar 2021 | - | $122.01 M(-4.7%) |
| Dec 2020 | $127.98 M(-9.0%) | $127.98 M(+8.2%) |
| Sept 2020 | - | $118.28 M(-7.6%) |
| June 2020 | - | $127.95 M(-1.3%) |
| Mar 2020 | - | $129.69 M(-7.8%) |
| Dec 2019 | $140.63 M(+13.3%) | $140.63 M(+2.3%) |
| Sept 2019 | - | $137.43 M(+2.6%) |
| June 2019 | - | $133.91 M(-3.0%) |
| Mar 2019 | - | $138.01 M(+11.2%) |
| Dec 2018 | $124.16 M | $124.16 M(-23.5%) |
| Sept 2018 | - | $162.36 M(+5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $153.86 M(+9.9%) |
| Mar 2018 | - | $140.06 M(-0.9%) |
| Dec 2017 | $141.40 M(+107.5%) | $141.40 M(-4.3%) |
| Sept 2017 | - | $147.76 M(+60.8%) |
| June 2017 | - | $91.91 M(+4.3%) |
| Mar 2017 | - | $88.13 M(+29.3%) |
| Dec 2016 | $68.14 M(-22.6%) | $68.14 M(-18.5%) |
| Sept 2016 | - | $83.60 M(-16.2%) |
| June 2016 | - | $99.72 M(+19.1%) |
| Mar 2016 | - | $83.75 M(-4.8%) |
| Dec 2015 | $88.00 M(+169.0%) | $88.00 M(+2.7%) |
| Sept 2015 | - | $85.72 M(-10.7%) |
| June 2015 | - | $95.97 M(-6.6%) |
| Mar 2015 | - | $102.74 M(+273.3%) |
| Dec 2014 | - | $27.52 M(-15.9%) |
| Sept 2014 | $32.71 M(+941.3%) | $32.71 M(-21.2%) |
| June 2014 | - | $41.51 M(-6.2%) |
| Mar 2014 | - | $44.26 M(<-9900.0%) |
| Dec 2013 | - | -$300.00 K(-109.6%) |
| Sept 2013 | $3.14 M(-126.1%) | $3.14 M |
| Sept 2012 | -$12.02 M | - |
FAQ
- What is Eagle Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Eagle Pharmaceuticals?
What is Eagle Pharmaceuticals annual working capital?
The current annual working capital of EGRX is $77.67 M
What is the all time high annual working capital for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual working capital is $141.40 M
What is Eagle Pharmaceuticals quarterly working capital?
The current quarterly working capital of EGRX is $100.62 M
What is the all time high quarterly working capital for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly working capital is $162.36 M